Rank | Gene Set | Z-score |
---|---|---|
1 | intestinal absorption (GO:0050892) | 9.53632126 |
2 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 8.37975759 |
3 | angiotensin maturation (GO:0002003) | 7.82580900 |
4 | intestinal cholesterol absorption (GO:0030299) | 7.44399985 |
5 | epoxygenase P450 pathway (GO:0019373) | 7.26622726 |
6 | lipoprotein transport (GO:0042953) | 7.21301014 |
7 | regulation of guanylate cyclase activity (GO:0031282) | 6.58118913 |
8 | maintenance of gastrointestinal epithelium (GO:0030277) | 6.52088307 |
9 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 6.25351111 |
10 | NADH metabolic process (GO:0006734) | 6.02875522 |
11 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.96131076 |
12 | transcytosis (GO:0045056) | 5.86607079 |
13 | intestinal epithelial cell development (GO:0060576) | 5.69139385 |
14 | actin filament depolymerization (GO:0030042) | 5.67207610 |
15 | vitamin A metabolic process (GO:0006776) | 5.43942290 |
16 | O-glycan processing (GO:0016266) | 5.26455354 |
17 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.19472513 |
18 | cellular glucuronidation (GO:0052695) | 5.18691356 |
19 | glucuronate metabolic process (GO:0019585) | 5.14308376 |
20 | uronic acid metabolic process (GO:0006063) | 5.14308376 |
21 | drug metabolic process (GO:0017144) | 5.14162648 |
22 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.09023273 |
23 | digestive system process (GO:0022600) | 4.95113590 |
24 | regulation of cellular extravasation (GO:0002691) | 4.93914229 |
25 | epithelial structure maintenance (GO:0010669) | 4.93275316 |
26 | urea cycle (GO:0000050) | 4.92820130 |
27 | fructose metabolic process (GO:0006000) | 4.92316630 |
28 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.92253735 |
29 | endocrine process (GO:0050886) | 4.92253735 |
30 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.92253735 |
31 | sulfate transmembrane transport (GO:1902358) | 4.90087797 |
32 | urea metabolic process (GO:0019627) | 4.86344047 |
33 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.82960402 |
34 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.82960402 |
35 | flavonoid metabolic process (GO:0009812) | 4.61436935 |
36 | striated muscle atrophy (GO:0014891) | 4.54296099 |
37 | nitrogen cycle metabolic process (GO:0071941) | 4.44693282 |
38 | regulation of systemic arterial blood pressure (GO:0003073) | 4.44493484 |
39 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.43872223 |
40 | L-fucose catabolic process (GO:0042355) | 4.41249680 |
41 | fucose catabolic process (GO:0019317) | 4.41249680 |
42 | L-fucose metabolic process (GO:0042354) | 4.41249680 |
43 | exogenous drug catabolic process (GO:0042738) | 4.41049337 |
44 | thrombin receptor signaling pathway (GO:0070493) | 4.35681315 |
45 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 4.22299838 |
46 | diacylglycerol metabolic process (GO:0046339) | 4.20364841 |
47 | hemidesmosome assembly (GO:0031581) | 4.19822283 |
48 | nucleotide-sugar metabolic process (GO:0009225) | 4.13521703 |
49 | hepatocyte apoptotic process (GO:0097284) | 4.05251943 |
50 | adhesion of symbiont to host cell (GO:0044650) | 4.04958428 |
51 | virion attachment to host cell (GO:0019062) | 4.04958428 |
52 | regulation of bile acid biosynthetic process (GO:0070857) | 4.04701955 |
53 | regulation of cGMP biosynthetic process (GO:0030826) | 4.02270971 |
54 | sulfate transport (GO:0008272) | 3.94442210 |
55 | skeletal muscle adaptation (GO:0043501) | 3.94070638 |
56 | regulation of vitamin metabolic process (GO:0030656) | 3.93140677 |
57 | galactose catabolic process (GO:0019388) | 3.91929672 |
58 | N-glycan processing (GO:0006491) | 3.88494029 |
59 | bile acid metabolic process (GO:0008206) | 3.88420274 |
60 | bile acid and bile salt transport (GO:0015721) | 3.87744569 |
61 | drug catabolic process (GO:0042737) | 3.87388323 |
62 | sperm capacitation (GO:0048240) | 3.85440550 |
63 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.84840423 |
64 | epithelial cell-cell adhesion (GO:0090136) | 3.84071007 |
65 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.83113032 |
66 | sulfation (GO:0051923) | 3.82098398 |
67 | arginine metabolic process (GO:0006525) | 3.81495043 |
68 | muscle atrophy (GO:0014889) | 3.79352977 |
69 | glycolipid catabolic process (GO:0019377) | 3.79330532 |
70 | glycosphingolipid catabolic process (GO:0046479) | 3.77226121 |
71 | midgut development (GO:0007494) | 3.76785312 |
72 | bicarbonate transport (GO:0015701) | 3.75477701 |
73 | regulation of cholesterol esterification (GO:0010872) | 3.73616439 |
74 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.71873490 |
75 | renal system process involved in regulation of blood volume (GO:0001977) | 3.70197224 |
76 | high-density lipoprotein particle remodeling (GO:0034375) | 3.69891727 |
77 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.69749496 |
78 | alkaloid metabolic process (GO:0009820) | 3.68845295 |
79 | homocysteine metabolic process (GO:0050667) | 3.63623418 |
80 | glucose 6-phosphate metabolic process (GO:0051156) | 3.62217644 |
81 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.57883665 |
82 | fat-soluble vitamin metabolic process (GO:0006775) | 3.57640397 |
83 | vitamin transmembrane transport (GO:0035461) | 3.56022948 |
84 | regulation of chemokine secretion (GO:0090196) | 3.55452011 |
85 | Peyers patch development (GO:0048541) | 3.52566964 |
86 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.52566964 |
87 | sulfur compound transport (GO:0072348) | 3.50828145 |
88 | protein-lipid complex remodeling (GO:0034368) | 3.47462683 |
89 | macromolecular complex remodeling (GO:0034367) | 3.47462683 |
90 | plasma lipoprotein particle remodeling (GO:0034369) | 3.47462683 |
91 | negative regulation of steroid metabolic process (GO:0045939) | 3.47247801 |
92 | mRNA modification (GO:0016556) | 3.45907143 |
93 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.44079581 |
94 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.44079581 |
95 | drinking behavior (GO:0042756) | 3.43425083 |
96 | antibacterial humoral response (GO:0019731) | 3.38971620 |
97 | regulation of cholesterol homeostasis (GO:2000188) | 3.38152208 |
98 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.37837575 |
99 | positive regulation of actin filament depolymerization (GO:0030836) | 3.36970211 |
100 | negative regulation of steroid biosynthetic process (GO:0010894) | 3.36636971 |
101 | antimicrobial humoral response (GO:0019730) | 3.36173763 |
102 | omega-hydroxylase P450 pathway (GO:0097267) | 3.35393909 |
103 | hormone catabolic process (GO:0042447) | 3.35049070 |
104 | positive regulation of pseudopodium assembly (GO:0031274) | 3.34236817 |
105 | regulation of cGMP metabolic process (GO:0030823) | 3.33526797 |
106 | digestion (GO:0007586) | 3.31742074 |
107 | vitamin transport (GO:0051180) | 3.30615170 |
108 | protein O-linked glycosylation (GO:0006493) | 3.30330656 |
109 | positive regulation of lipid catabolic process (GO:0050996) | 3.29522975 |
110 | cellular response to nitric oxide (GO:0071732) | 3.28135874 |
111 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.27439934 |
112 | response to hepatocyte growth factor (GO:0035728) | 3.27439934 |
113 | plasma lipoprotein particle organization (GO:0071827) | 3.23619823 |
114 | reverse cholesterol transport (GO:0043691) | 3.19653558 |
115 | sulfur amino acid catabolic process (GO:0000098) | 3.18720235 |
116 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.17909778 |
117 | regulation of actin nucleation (GO:0051125) | 3.17221782 |
118 | glycerol metabolic process (GO:0006071) | 3.17104044 |
119 | ethanol oxidation (GO:0006069) | 3.16699435 |
120 | vitamin biosynthetic process (GO:0009110) | 3.16653255 |
121 | transepithelial transport (GO:0070633) | 3.15571366 |
122 | vitamin D metabolic process (GO:0042359) | 3.14837533 |
123 | thyroid hormone metabolic process (GO:0042403) | 3.14820618 |
124 | adhesion of symbiont to host (GO:0044406) | 3.14462355 |
125 | interferon-gamma secretion (GO:0072643) | 3.11169089 |
126 | defense response to fungus (GO:0050832) | 3.09887007 |
127 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.09501005 |
128 | protein-lipid complex subunit organization (GO:0071825) | 3.07185311 |
129 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.04943080 |
130 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.04943080 |
131 | citrulline biosynthetic process (GO:0019240) | 3.04180518 |
132 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.03328841 |
133 | cholesterol efflux (GO:0033344) | 3.03224107 |
134 | fucose metabolic process (GO:0006004) | 3.02950088 |
135 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 3.01842491 |
136 | hexose catabolic process (GO:0019320) | 3.01758269 |
137 | ceramide catabolic process (GO:0046514) | 3.01095770 |
138 | negative regulation of hormone metabolic process (GO:0032351) | 3.00209919 |
139 | L-ascorbic acid metabolic process (GO:0019852) | 2.98534984 |
140 | glycosylceramide metabolic process (GO:0006677) | 2.98259143 |
141 | regulation of pseudopodium assembly (GO:0031272) | 2.98109905 |
142 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.97550530 |
143 | plasma lipoprotein particle assembly (GO:0034377) | 2.96835908 |
144 | modified amino acid transport (GO:0072337) | 2.96289430 |
145 | phospholipid efflux (GO:0033700) | 2.95747476 |
146 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.95057783 |
147 | regulation of triglyceride catabolic process (GO:0010896) | 2.93733294 |
148 | peptide catabolic process (GO:0043171) | 2.93118053 |
149 | lipoprotein metabolic process (GO:0042157) | 2.91111161 |
150 | protein-lipid complex assembly (GO:0065005) | 2.85064602 |
151 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.83990574 |
152 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.83399523 |
153 | negative regulation of cholesterol transport (GO:0032375) | 2.77856010 |
154 | negative regulation of sterol transport (GO:0032372) | 2.77856010 |
155 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.77243689 |
156 | peptide hormone processing (GO:0016486) | 2.76654106 |
157 | galactose metabolic process (GO:0006012) | 2.75181936 |
158 | regulation of respiratory burst (GO:0060263) | 2.71793512 |
159 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.71112265 |
160 | desmosome organization (GO:0002934) | 2.70520087 |
161 | GDP-mannose metabolic process (GO:0019673) | 2.70406547 |
162 | cGMP-mediated signaling (GO:0019934) | 2.69290387 |
163 | hypotonic response (GO:0006971) | 2.69218669 |
164 | lung secretory cell differentiation (GO:0061140) | 2.68455256 |
165 | tight junction assembly (GO:0070830) | 2.67919141 |
166 | lipid translocation (GO:0034204) | 2.67812918 |
167 | phospholipid translocation (GO:0045332) | 2.67812918 |
168 | drug transport (GO:0015893) | 2.67575546 |
169 | cholesterol homeostasis (GO:0042632) | 2.65861349 |
170 | neural tube formation (GO:0001841) | 2.65605009 |
171 | sterol homeostasis (GO:0055092) | 2.65136922 |
172 | killing of cells of other organism (GO:0031640) | 2.64789799 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.64500196 |
2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.95672700 |
3 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 4.14075707 |
4 | GATA4_25053715_ChIP-Seq_YYC3_Human | 3.26314379 |
5 | GATA6_25053715_ChIP-Seq_YYC3_Human | 3.11679581 |
6 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.98129489 |
7 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.80119628 |
8 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.75940864 |
9 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.74932039 |
10 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.69091003 |
11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.60117921 |
12 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.51436843 |
13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.35541047 |
14 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.31766537 |
15 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.23888806 |
16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.17301025 |
17 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 2.09117949 |
18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.08359428 |
19 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.05953972 |
20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.04127583 |
21 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.01211193 |
22 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.97681074 |
23 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.97062224 |
24 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.96486171 |
25 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.93959662 |
26 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.91826765 |
27 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.84980848 |
28 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.84904885 |
29 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.84502690 |
30 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.83074240 |
31 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.78242116 |
32 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.77811915 |
33 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.77233899 |
34 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.73772008 |
35 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.73537064 |
36 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.73536671 |
37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.71544894 |
38 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.70590046 |
39 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.66330183 |
40 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.63416395 |
41 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.61448654 |
42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.60898890 |
43 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.58789850 |
44 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.56527194 |
45 | GATA2_19941826_ChIP-Seq_K562_Human | 1.55675255 |
46 | ATF3_27146783_Chip-Seq_COLON_Human | 1.54266233 |
47 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.53820144 |
48 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.52337630 |
49 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.50907365 |
50 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.46716578 |
51 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.43037378 |
52 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.42666931 |
53 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.35572477 |
54 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.35546834 |
55 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.34870417 |
56 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.34870417 |
57 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.31401975 |
58 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.30216291 |
59 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.28764290 |
60 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.27889805 |
61 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.26755532 |
62 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.24181386 |
63 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.21318177 |
64 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.18095337 |
65 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.17987503 |
66 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.17692339 |
67 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.17411521 |
68 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.16698863 |
69 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.16312445 |
70 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.14782529 |
71 | RXR_22108803_ChIP-Seq_LS180_Human | 1.14130579 |
72 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.14124285 |
73 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.13846437 |
74 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.10211911 |
75 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07403066 |
76 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06232355 |
77 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.03796094 |
78 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03342454 |
79 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.03293092 |
80 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.02322894 |
81 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.02062870 |
82 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01958184 |
83 | TP53_16413492_ChIP-PET_HCT116_Human | 1.01522267 |
84 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.01437185 |
85 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.01278230 |
86 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.00439950 |
87 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00075583 |
88 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.99465171 |
89 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.99444127 |
90 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.99243872 |
91 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.98174792 |
92 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.98118326 |
93 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.98079411 |
94 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.97639918 |
95 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.96764897 |
96 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94435278 |
97 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.94283393 |
98 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93104568 |
99 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.92625039 |
100 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.91687712 |
101 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.90713613 |
102 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.89210411 |
103 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87789064 |
104 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86949018 |
105 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.86314710 |
106 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.86051952 |
107 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.84686490 |
108 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.84516421 |
109 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.84414389 |
110 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.84136597 |
111 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.83628696 |
112 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.83614041 |
113 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.82942202 |
114 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.81615950 |
115 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.81589282 |
116 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.81021816 |
117 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.80398801 |
118 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.80230879 |
119 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.79811232 |
120 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.79577520 |
121 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.78685347 |
122 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.78377222 |
123 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.78286063 |
124 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.77717857 |
125 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.77098796 |
126 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.77089873 |
127 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.76922557 |
128 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76862812 |
129 | UTX_26944678_Chip-Seq_JUKART_Human | 0.76633273 |
130 | SPI1_23127762_ChIP-Seq_K562_Human | 0.75892764 |
131 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.75667946 |
132 | CJUN_26792858_Chip-Seq_BT549_Human | 0.75589624 |
133 | VDR_22108803_ChIP-Seq_LS180_Human | 0.75382828 |
134 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75159620 |
135 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.75022235 |
136 | CBP_21632823_ChIP-Seq_H3396_Human | 0.74375877 |
137 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.72219743 |
138 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.69873956 |
139 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.68975770 |
140 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.67722006 |
141 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.67629808 |
142 | NFYA_21822215_ChIP-Seq_K562_Human | 0.67542123 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0010234_abnormal_vibrissa_follicle | 5.86673837 |
2 | MP0005360_urolithiasis | 5.20155707 |
3 | MP0004264_abnormal_extraembryonic_tissu | 4.73271185 |
4 | MP0003866_abnormal_defecation | 4.50531902 |
5 | MP0001666_abnormal_nutrient_absorption | 4.40298031 |
6 | MP0003300_gastrointestinal_ulcer | 3.70730565 |
7 | MP0000462_abnormal_digestive_system | 3.31161760 |
8 | MP0010155_abnormal_intestine_physiology | 3.10783332 |
9 | MP0010352_gastrointestinal_tract_polyps | 2.79486950 |
10 | MP0005085_abnormal_gallbladder_physiolo | 2.76055233 |
11 | MP0001663_abnormal_digestive_system | 2.72844462 |
12 | MP0001873_stomach_inflammation | 2.72204625 |
13 | MP0003252_abnormal_bile_duct | 2.59634126 |
14 | MP0005381_digestive/alimentary_phenotyp | 2.52463126 |
15 | MP0000537_abnormal_urethra_morphology | 2.46366464 |
16 | MP0000490_abnormal_crypts_of | 2.41884916 |
17 | MP0000477_abnormal_intestine_morphology | 2.32960803 |
18 | MP0004147_increased_porphyrin_level | 2.30273289 |
19 | MP0006054_spinal_hemorrhage | 2.26960518 |
20 | MP0003183_abnormal_peptide_metabolism | 2.24321973 |
21 | MP0001664_abnormal_digestion | 2.22732015 |
22 | MP0005409_darkened_coat_color | 1.99965929 |
23 | MP0002822_catalepsy | 1.96026616 |
24 | MP0008875_abnormal_xenobiotic_pharmacok | 1.95488919 |
25 | MP0003705_abnormal_hypodermis_morpholog | 1.86973438 |
26 | MP0005377_hearing/vestibular/ear_phenot | 1.83638210 |
27 | MP0003878_abnormal_ear_physiology | 1.83638210 |
28 | MP0009840_abnormal_foam_cell | 1.83233033 |
29 | MP0002139_abnormal_hepatobiliary_system | 1.80681440 |
30 | MP0002009_preneoplasia | 1.73396090 |
31 | MP0000538_abnormal_urinary_bladder | 1.64845824 |
32 | MP0002254_reproductive_system_inflammat | 1.64150068 |
33 | MP0005365_abnormal_bile_salt | 1.63839635 |
34 | MP0010678_abnormal_skin_adnexa | 1.62946636 |
35 | MP0005310_abnormal_salivary_gland | 1.53781045 |
36 | MP0010329_abnormal_lipoprotein_level | 1.52378807 |
37 | MP0002166_altered_tumor_susceptibility | 1.44591670 |
38 | MP0004858_abnormal_nervous_system | 1.43276090 |
39 | MP0001765_abnormal_ion_homeostasis | 1.40958161 |
40 | MP0004043_abnormal_pH_regulation | 1.40627226 |
41 | MP0002796_impaired_skin_barrier | 1.38877749 |
42 | MP0001849_ear_inflammation | 1.32969615 |
43 | MP0002006_tumorigenesis | 1.32114859 |
44 | MP0003868_abnormal_feces_composition | 1.29498035 |
45 | MP0009379_abnormal_foot_pigmentation | 1.21965913 |
46 | MP0000566_synostosis | 1.21929562 |
47 | MP0005167_abnormal_blood-brain_barrier | 1.21788125 |
48 | MP0002098_abnormal_vibrissa_morphology | 1.19564131 |
49 | MP0005501_abnormal_skin_physiology | 1.19543064 |
50 | MP0000465_gastrointestinal_hemorrhage | 1.18872563 |
51 | MP0004947_skin_inflammation | 1.16655115 |
52 | MP0004782_abnormal_surfactant_physiolog | 1.15637629 |
53 | MP0003453_abnormal_keratinocyte_physiol | 1.14537052 |
54 | MP0000467_abnormal_esophagus_morphology | 1.10221389 |
55 | MP0005670_abnormal_white_adipose | 1.09870503 |
56 | MP0001188_hyperpigmentation | 1.09673925 |
57 | MP0000678_abnormal_parathyroid_gland | 1.07806638 |
58 | MP0009643_abnormal_urine_homeostasis | 1.04219219 |
59 | MP0005636_abnormal_mineral_homeostasis | 1.02493204 |
60 | MP0005166_decreased_susceptibility_to | 1.01602914 |
61 | MP0001501_abnormal_sleep_pattern | 1.00660258 |
62 | MP0000470_abnormal_stomach_morphology | 0.99988405 |
63 | MP0002971_abnormal_brown_adipose | 0.97780667 |
64 | MP0004019_abnormal_vitamin_homeostasis | 0.95498318 |
65 | MP0009697_abnormal_copulation | 0.95175824 |
66 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.95026111 |
67 | MP0001216_abnormal_epidermal_layer | 0.93397779 |
68 | MP0004270_analgesia | 0.93345930 |
69 | MP0000516_abnormal_urinary_system | 0.86325225 |
70 | MP0005367_renal/urinary_system_phenotyp | 0.86325225 |
71 | MP0008872_abnormal_physiological_respon | 0.85397404 |
72 | MP0002277_abnormal_respiratory_mucosa | 0.85206940 |
73 | MP0003045_fibrosis | 0.85173313 |
74 | MP0003879_abnormal_hair_cell | 0.85110171 |
75 | MP0008775_abnormal_heart_ventricle | 0.85103727 |
76 | MP0002138_abnormal_hepatobiliary_system | 0.83200593 |
77 | MP0003566_abnormal_cell_adhesion | 0.83025263 |
78 | MP0005535_abnormal_body_temperature | 0.82008199 |
79 | MP0009785_altered_susceptibility_to | 0.79995940 |
80 | MP0003436_decreased_susceptibility_to | 0.78839995 |
81 | MP0004215_abnormal_myocardial_fiber | 0.78423470 |
82 | MP0002060_abnormal_skin_morphology | 0.76864226 |
83 | MP0000609_abnormal_liver_physiology | 0.76603937 |
84 | MP0001845_abnormal_inflammatory_respons | 0.75882266 |
85 | MP0001485_abnormal_pinna_reflex | 0.75753186 |
86 | MP0000613_abnormal_salivary_gland | 0.75508635 |
87 | MP0004145_abnormal_muscle_electrophysio | 0.74844982 |
88 | MP0000230_abnormal_systemic_arterial | 0.74792521 |
89 | MP0005025_abnormal_response_to | 0.74757914 |
90 | MP0002089_abnormal_postnatal_growth/wei | 0.74423767 |
91 | MP0009115_abnormal_fat_cell | 0.73837821 |
92 | MP0003315_abnormal_perineum_morphology | 0.73381601 |
93 | MP0003283_abnormal_digestive_organ | 0.73219939 |
94 | MP0005464_abnormal_platelet_physiology | 0.72620030 |
95 | MP0009384_cardiac_valve_regurgitation | 0.72471561 |
96 | MP0003191_abnormal_cellular_cholesterol | 0.71080029 |
97 | MP0003693_abnormal_embryo_hatching | 0.69916121 |
98 | MP0000377_abnormal_hair_follicle | 0.69570567 |
99 | MP0000604_amyloidosis | 0.69503213 |
100 | MP0009642_abnormal_blood_homeostasis | 0.68106349 |
101 | MP0005448_abnormal_energy_balance | 0.66612687 |
102 | MP0002136_abnormal_kidney_physiology | 0.65599928 |
103 | MP0003806_abnormal_nucleotide_metabolis | 0.64049145 |
104 | MP0005451_abnormal_body_composition | 0.63997066 |
105 | MP0003329_amyloid_beta_deposits | 0.63870542 |
106 | MP0001881_abnormal_mammary_gland | 0.63296601 |
107 | MP0005319_abnormal_enzyme/_coenzyme | 0.62860127 |
108 | MP0010771_integument_phenotype | 0.61734353 |
109 | MP0003941_abnormal_skin_development | 0.61210497 |
110 | MP0001764_abnormal_homeostasis | 0.60733072 |
111 | MP0002876_abnormal_thyroid_physiology | 0.59205325 |
112 | MP0003718_maternal_effect | 0.58687060 |
113 | MP0003303_peritoneal_inflammation | 0.58514667 |
114 | MP0002896_abnormal_bone_mineralization | 0.58045403 |
115 | MP0000383_abnormal_hair_follicle | 0.56956287 |
116 | MP0006138_congestive_heart_failure | 0.56783627 |
117 | MP0005666_abnormal_adipose_tissue | 0.56690192 |
118 | MP0005334_abnormal_fat_pad | 0.56423390 |
119 | MP0002148_abnormal_hypersensitivity_rea | 0.54969023 |
120 | MP0000249_abnormal_blood_vessel | 0.54899580 |
121 | MP0008004_abnormal_stomach_pH | 0.53314375 |
122 | MP0009780_abnormal_chondrocyte_physiolo | 0.53257089 |
123 | MP0002396_abnormal_hematopoietic_system | 0.51384548 |
124 | MP0002118_abnormal_lipid_homeostasis | 0.50429259 |
125 | MP0002132_abnormal_respiratory_system | 0.50324492 |
126 | MP0003724_increased_susceptibility_to | 0.49898420 |
127 | MP0008873_increased_physiological_sensi | 0.49881386 |
128 | MP0009053_abnormal_anal_canal | 0.48618144 |
129 | MP0005084_abnormal_gallbladder_morpholo | 0.47379804 |
130 | MP0005395_other_phenotype | 0.47054336 |
131 | MP0009764_decreased_sensitivity_to | 0.47028909 |
132 | MP0001756_abnormal_urination | 0.46827889 |
133 | MP0005165_increased_susceptibility_to | 0.46760454 |
134 | MP0002078_abnormal_glucose_homeostasis | 0.46416181 |
135 | MP0009765_abnormal_xenobiotic_induced | 0.46248415 |
136 | MP0003953_abnormal_hormone_level | 0.45318729 |
137 | MP0010307_abnormal_tumor_latency | 0.43647298 |
138 | MP0008469_abnormal_protein_level | 0.43285585 |
139 | MP0005332_abnormal_amino_acid | 0.42149105 |
140 | MP0004510_myositis | 0.41470284 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ileus (HP:0002595) | 8.77585796 |
2 | Right ventricular cardiomyopathy (HP:0011663) | 6.43821433 |
3 | Acanthocytosis (HP:0001927) | 4.92870018 |
4 | Malnutrition (HP:0004395) | 4.72112235 |
5 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.65228858 |
6 | Systemic lupus erythematosus (HP:0002725) | 4.61379552 |
7 | Hyperactive renin-angiotensin system (HP:0000841) | 4.33953529 |
8 | Abdominal distention (HP:0003270) | 4.25157260 |
9 | Chronic diarrhea (HP:0002028) | 4.23966238 |
10 | Abnormality of proline metabolism (HP:0010907) | 4.12609393 |
11 | Hydroxyprolinuria (HP:0003080) | 4.12609393 |
12 | Conjugated hyperbilirubinemia (HP:0002908) | 3.98526397 |
13 | Metabolic alkalosis (HP:0200114) | 3.96061091 |
14 | Hypobetalipoproteinemia (HP:0003563) | 3.77109578 |
15 | Confusion (HP:0001289) | 3.72745877 |
16 | Proximal tubulopathy (HP:0000114) | 3.67635188 |
17 | Gastrointestinal dysmotility (HP:0002579) | 3.61160381 |
18 | Glycosuria (HP:0003076) | 3.59803590 |
19 | Abnormality of urine glucose concentration (HP:0011016) | 3.59803590 |
20 | Milia (HP:0001056) | 3.56819075 |
21 | Abnormality of chloride homeostasis (HP:0011422) | 3.55044795 |
22 | Flat acetabular roof (HP:0003180) | 3.52188104 |
23 | Nausea (HP:0002018) | 3.47908134 |
24 | Xanthomatosis (HP:0000991) | 3.35099851 |
25 | Pili torti (HP:0003777) | 3.34578745 |
26 | Rectal prolapse (HP:0002035) | 3.34018571 |
27 | Villous atrophy (HP:0011473) | 3.28836175 |
28 | Abnormality of small intestinal villus morphology (HP:0011472) | 3.28836175 |
29 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.21073946 |
30 | Steatorrhea (HP:0002570) | 3.19244709 |
31 | Abnormality of glycine metabolism (HP:0010895) | 3.18678349 |
32 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.18678349 |
33 | Wide cranial sutures (HP:0010537) | 3.15625286 |
34 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.13994478 |
35 | Fat malabsorption (HP:0002630) | 3.13593809 |
36 | Glomerulonephritis (HP:0000099) | 3.11824264 |
37 | Nephrolithiasis (HP:0000787) | 3.10706584 |
38 | Ureteral stenosis (HP:0000071) | 3.07813128 |
39 | Hyperammonemia (HP:0001987) | 3.06810409 |
40 | Autoimmune thrombocytopenia (HP:0001973) | 3.06276444 |
41 | Onycholysis (HP:0001806) | 3.05379356 |
42 | Complement deficiency (HP:0004431) | 3.02597422 |
43 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.01145681 |
44 | Dehydration (HP:0001944) | 2.99454466 |
45 | Abnormal tarsal ossification (HP:0008369) | 2.98964803 |
46 | Woolly hair (HP:0002224) | 2.98187401 |
47 | Ureteral obstruction (HP:0006000) | 2.98083171 |
48 | Petechiae (HP:0000967) | 2.90363282 |
49 | Poikilocytosis (HP:0004447) | 2.89509881 |
50 | Abnormality of complement system (HP:0005339) | 2.85514518 |
51 | Autoimmune hemolytic anemia (HP:0001890) | 2.83440630 |
52 | Increased purine levels (HP:0004368) | 2.83156593 |
53 | Hyperuricemia (HP:0002149) | 2.83156593 |
54 | Abnormal biliary tract morphology (HP:0012440) | 2.76287285 |
55 | Palpitations (HP:0001962) | 2.74611640 |
56 | Pustule (HP:0200039) | 2.74423202 |
57 | Fragile nails (HP:0001808) | 2.70441308 |
58 | Abnormality of renin-angiotensin system (HP:0000847) | 2.69156390 |
59 | Atrophic scars (HP:0001075) | 2.67919799 |
60 | Abnormality of the gastric mucosa (HP:0004295) | 2.64778144 |
61 | Nephritis (HP:0000123) | 2.63258065 |
62 | Facial shape deformation (HP:0011334) | 2.62745642 |
63 | Potter facies (HP:0002009) | 2.62745642 |
64 | Megaloblastic anemia (HP:0001889) | 2.61410482 |
65 | Abnormal foot bone ossification (HP:0010675) | 2.61128142 |
66 | Posterior subcapsular cataract (HP:0007787) | 2.60886306 |
67 | Epidermoid cyst (HP:0200040) | 2.60117669 |
68 | Decreased circulating renin level (HP:0003351) | 2.59681633 |
69 | Abnormality of purine metabolism (HP:0004352) | 2.59544671 |
70 | Abnormality of the 1st metacarpal (HP:0010009) | 2.59274836 |
71 | Progressive sensorineural hearing impairment (HP:0000408) | 2.58840502 |
72 | Hypophosphatemia (HP:0002148) | 2.55284548 |
73 | Abnormality of nucleobase metabolism (HP:0010932) | 2.54607323 |
74 | Plantar hyperkeratosis (HP:0007556) | 2.53902450 |
75 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.52689410 |
76 | Eczematoid dermatitis (HP:0000976) | 2.50365425 |
77 | Cupped ribs (HP:0000887) | 2.47244988 |
78 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.43834926 |
79 | Hypotension (HP:0002615) | 2.41797150 |
80 | Vertebral clefting (HP:0008428) | 2.40975190 |
81 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.40154792 |
82 | Micronodular cirrhosis (HP:0001413) | 2.37521740 |
83 | Biliary tract neoplasm (HP:0100574) | 2.36860160 |
84 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.35059765 |
85 | Abnormal urine phosphate concentration (HP:0012599) | 2.34727072 |
86 | Enlarged epiphyses (HP:0010580) | 2.31708820 |
87 | Hyperphosphaturia (HP:0003109) | 2.31269488 |
88 | Thrombocytosis (HP:0001894) | 2.28410805 |
89 | Metabolic acidosis (HP:0001942) | 2.27416530 |
90 | Hyperparathyroidism (HP:0000843) | 2.27362683 |
91 | Progressive hearing impairment (HP:0001730) | 2.26713847 |
92 | Hemorrhage of the eye (HP:0011885) | 2.25207118 |
93 | Focal segmental glomerulosclerosis (HP:0000097) | 2.25097243 |
94 | Periodontitis (HP:0000704) | 2.24543354 |
95 | Delayed epiphyseal ossification (HP:0002663) | 2.24312230 |
96 | Microretrognathia (HP:0000308) | 2.22558804 |
97 | Widely patent fontanelles and sutures (HP:0004492) | 2.21699179 |
98 | Abnormality of vitamin B metabolism (HP:0004340) | 2.18382092 |
99 | Increased IgE level (HP:0003212) | 2.16194935 |
100 | Congenital sensorineural hearing impairment (HP:0008527) | 2.16086807 |
101 | Pigmentary retinal degeneration (HP:0001146) | 2.16022359 |
102 | Aortic aneurysm (HP:0004942) | 2.15317144 |
103 | Intrahepatic cholestasis (HP:0001406) | 2.15226135 |
104 | Blepharitis (HP:0000498) | 2.14304228 |
105 | Ventricular fibrillation (HP:0001663) | 2.12261181 |
106 | Syncope (HP:0001279) | 2.11847175 |
107 | Abnormal hair laboratory examination (HP:0003328) | 2.11162355 |
108 | Abnormality of the costochondral junction (HP:0000919) | 2.10548272 |
109 | Thin bony cortex (HP:0002753) | 2.06266380 |
110 | Protuberant abdomen (HP:0001538) | 2.05423817 |
111 | Subcapsular cataract (HP:0000523) | 2.05205253 |
112 | Hyperglycinuria (HP:0003108) | 2.04224247 |
113 | Increased mean platelet volume (HP:0011877) | 2.03731235 |
114 | Fragile skin (HP:0001030) | 2.03659186 |
115 | Flattened epiphyses (HP:0003071) | 2.03413790 |
116 | Bundle branch block (HP:0011710) | 2.01257706 |
117 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.98875071 |
118 | Abnormal platelet volume (HP:0011876) | 1.97977590 |
119 | Gout (HP:0001997) | 1.97731424 |
120 | Reduced antithrombin III activity (HP:0001976) | 1.97642619 |
121 | Myopathic facies (HP:0002058) | 1.96881962 |
122 | Abnormality of carpal bone ossification (HP:0006257) | 1.96162614 |
123 | Neoplasm of the rectum (HP:0100743) | 1.95996723 |
124 | Cerebral palsy (HP:0100021) | 1.95944013 |
125 | Neoplasm of the small intestine (HP:0100833) | 1.95918097 |
126 | Hyperlipoproteinemia (HP:0010980) | 1.95704000 |
127 | Renal tubular acidosis (HP:0001947) | 1.95535917 |
128 | Curly hair (HP:0002212) | 1.95267384 |
129 | Abnormality of magnesium homeostasis (HP:0004921) | 1.94776731 |
130 | Hypolipoproteinemia (HP:0010981) | 1.93582262 |
131 | Deviation of the thumb (HP:0009603) | 1.91914978 |
132 | Fatigue (HP:0012378) | 1.91785092 |
133 | Hoarse voice (HP:0001609) | 1.91597913 |
134 | Hypoplasia of dental enamel (HP:0006297) | 1.91038993 |
135 | Cone-rod dystrophy (HP:0000548) | 1.91020815 |
136 | Proximal placement of thumb (HP:0009623) | 1.90939543 |
137 | Goiter (HP:0000853) | 1.88652280 |
138 | Irritability (HP:0000737) | 1.87899632 |
139 | Ventricular tachycardia (HP:0004756) | 1.85721771 |
140 | Gingivitis (HP:0000230) | 1.84764560 |
141 | Dicarboxylic aciduria (HP:0003215) | 1.84737438 |
142 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.84737438 |
143 | Alkalosis (HP:0001948) | 1.83433248 |
144 | Hyperaldosteronism (HP:0000859) | 1.82984408 |
145 | Uterine neoplasm (HP:0010784) | 1.82005468 |
146 | Cheilitis (HP:0100825) | 1.80215697 |
147 | Glomerulosclerosis (HP:0000096) | 1.79820831 |
148 | Male infertility (HP:0003251) | 1.79332378 |
149 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.78054665 |
150 | Abnormality of vitamin metabolism (HP:0100508) | 1.77874524 |
151 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77625510 |
152 | Abnormal glucose tolerance (HP:0001952) | 1.76567313 |
153 | Pancreatitis (HP:0001733) | 1.76424641 |
154 | Chorioretinal atrophy (HP:0000533) | 1.75897835 |
155 | Prostate neoplasm (HP:0100787) | 1.73370442 |
156 | Abnormal cartilage morphology (HP:0002763) | 1.73301973 |
157 | Skin nodule (HP:0200036) | 1.70174886 |
158 | Patchy hypopigmentation of hair (HP:0011365) | 1.69862263 |
159 | Peripheral demyelination (HP:0011096) | 1.66849702 |
160 | Hypokalemia (HP:0002900) | 1.65054945 |
161 | White forelock (HP:0002211) | 1.63504090 |
162 | Hyperphosphatemia (HP:0002905) | 1.63452070 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ACVR1B | 7.86561405 |
2 | FRK | 6.45789344 |
3 | MST4 | 5.65140071 |
4 | LMTK2 | 5.47048130 |
5 | MST1R | 3.78501799 |
6 | NUAK1 | 3.50759397 |
7 | PIK3CA | 3.14565096 |
8 | CASK | 2.95900010 |
9 | PRKG2 | 2.75892071 |
10 | MAP2K2 | 2.63418851 |
11 | DMPK | 2.52746394 |
12 | MYLK | 2.25390405 |
13 | TESK1 | 2.07260754 |
14 | RIPK1 | 2.06929200 |
15 | OBSCN | 2.04739920 |
16 | NME1 | 2.03609694 |
17 | EPHA3 | 2.03446118 |
18 | FGFR4 | 2.02613435 |
19 | EPHB2 | 1.94296661 |
20 | MAP3K7 | 1.90066612 |
21 | PTK6 | 1.87274799 |
22 | STK24 | 1.80008269 |
23 | TNIK | 1.68848628 |
24 | GRK6 | 1.67567541 |
25 | TAOK3 | 1.63635312 |
26 | MAP3K2 | 1.61472847 |
27 | EEF2K | 1.54911447 |
28 | EPHA2 | 1.51718048 |
29 | AKT3 | 1.51042241 |
30 | MAP3K10 | 1.48696165 |
31 | RAF1 | 1.27872189 |
32 | NLK | 1.25796145 |
33 | MATK | 1.24575581 |
34 | PDGFRA | 1.21408625 |
35 | PKN2 | 1.16556918 |
36 | RIPK4 | 1.13640887 |
37 | ERN1 | 1.11689924 |
38 | STK38L | 1.09475434 |
39 | TAOK1 | 1.09140187 |
40 | EPHA4 | 1.09010509 |
41 | FLT3 | 1.07787614 |
42 | MET | 1.06832460 |
43 | TEC | 0.99866394 |
44 | STK10 | 0.98361400 |
45 | ERBB2 | 0.97532111 |
46 | SCYL2 | 0.94806130 |
47 | PAK4 | 0.93452451 |
48 | MAP2K1 | 0.89968472 |
49 | LRRK2 | 0.86965517 |
50 | KSR2 | 0.82200736 |
51 | LIMK1 | 0.81389796 |
52 | PRKACG | 0.79258512 |
53 | PRKCI | 0.78611320 |
54 | MAP3K8 | 0.78275992 |
55 | FER | 0.76626317 |
56 | RET | 0.76472694 |
57 | EPHB1 | 0.73410475 |
58 | PIM1 | 0.71517125 |
59 | MAP2K6 | 0.71124447 |
60 | STK39 | 0.70741193 |
61 | MAP3K12 | 0.68953040 |
62 | MUSK | 0.62658297 |
63 | IRAK1 | 0.61874269 |
64 | PDPK1 | 0.60950022 |
65 | JAK2 | 0.60652544 |
66 | PRKAA2 | 0.60505072 |
67 | JAK1 | 0.57918358 |
68 | PTK2 | 0.57130305 |
69 | CDC42BPA | 0.57085227 |
70 | PIK3CG | 0.57022347 |
71 | LATS1 | 0.55437761 |
72 | PAK2 | 0.54680734 |
73 | PRPF4B | 0.53937540 |
74 | TBK1 | 0.53896682 |
75 | KDR | 0.53312685 |
76 | PDK1 | 0.52771056 |
77 | DDR2 | 0.51798669 |
78 | ILK | 0.51555508 |
79 | MAPKAPK3 | 0.51320488 |
80 | PAK1 | 0.50664995 |
81 | TYK2 | 0.50522125 |
82 | RPS6KB2 | 0.50441058 |
83 | PRKCZ | 0.50047164 |
84 | TTK | 0.48835647 |
85 | AURKB | 0.47840712 |
86 | TESK2 | 0.45831016 |
87 | BMX | 0.43116283 |
88 | ROCK1 | 0.42554481 |
89 | MAPK11 | 0.41586012 |
90 | STK3 | 0.40863022 |
91 | MAP3K1 | 0.39967073 |
92 | CSK | 0.38238834 |
93 | BMPR2 | 0.36658762 |
94 | CDK6 | 0.35692024 |
95 | TRIB3 | 0.35592923 |
96 | YES1 | 0.33025469 |
97 | OXSR1 | 0.32699532 |
98 | MELK | 0.31163192 |
99 | DYRK1B | 0.30845438 |
100 | PRKAA1 | 0.29445248 |
101 | MAP3K6 | 0.27241652 |
102 | MAP3K5 | 0.27162908 |
103 | ABL2 | 0.25753582 |
104 | MAP4K1 | 0.25201242 |
105 | SRC | 0.24877134 |
106 | PRKCD | 0.23808459 |
107 | ITK | 0.23793841 |
108 | IKBKE | 0.22941452 |
109 | PIM2 | 0.22548341 |
110 | IGF1R | 0.22516661 |
111 | TTN | 0.22445521 |
112 | FGFR1 | 0.22412583 |
113 | FGFR3 | 0.21887177 |
114 | ICK | 0.20758759 |
115 | MAPKAPK2 | 0.20502186 |
116 | ROCK2 | 0.19811606 |
117 | TRPM7 | 0.19620604 |
118 | CAMK2G | 0.19509382 |
119 | PDK2 | 0.19363642 |
120 | FYN | 0.18915728 |
121 | CDK19 | 0.18386850 |
122 | PRKACA | 0.18169124 |
123 | GRK1 | 0.18024395 |
124 | TGFBR1 | 0.17596213 |
125 | MAP3K11 | 0.16656006 |
126 | RPS6KB1 | 0.16397967 |
127 | PRKCQ | 0.16189918 |
128 | CSNK1A1 | 0.15926622 |
129 | CAMK2D | 0.15591818 |
130 | MAPK7 | 0.15578346 |
131 | GRK7 | 0.15495335 |
132 | PDGFRB | 0.14951098 |
133 | PRKCA | 0.13590086 |
134 | CDK4 | 0.13282604 |
135 | PRKG1 | 0.12203487 |
136 | MAP3K3 | 0.12083409 |
137 | PAK3 | 0.10234586 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.40849632 |
2 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.31458579 |
3 | Mineral absorption_Homo sapiens_hsa04978 | 4.22747809 |
4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.12452963 |
5 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.68719311 |
6 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 3.26660618 |
7 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.96443676 |
8 | Galactose metabolism_Homo sapiens_hsa00052 | 2.66368060 |
9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.28681485 |
10 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.24765421 |
11 | Bile secretion_Homo sapiens_hsa04976 | 2.17884983 |
12 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.16189647 |
13 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.11967737 |
14 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.09739469 |
15 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.05321073 |
16 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.02706439 |
17 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.99937557 |
18 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.92064019 |
19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.86800718 |
20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.85841600 |
21 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.82466588 |
22 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.81237206 |
23 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.73321868 |
24 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.42270573 |
25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.41878434 |
26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.34413617 |
27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.30860538 |
28 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.16627600 |
29 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.15554262 |
30 | Tight junction_Homo sapiens_hsa04530 | 1.14637580 |
31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.08690820 |
32 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.08486464 |
33 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.07878941 |
34 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.07219764 |
35 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.06390251 |
36 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.04971484 |
37 | Adherens junction_Homo sapiens_hsa04520 | 1.00077169 |
38 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.99738516 |
39 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.95987556 |
40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.93334525 |
41 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.93034566 |
42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91775820 |
43 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.90644902 |
44 | Asthma_Homo sapiens_hsa05310 | 0.90184299 |
45 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.89662621 |
46 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.87381627 |
47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.87326060 |
48 | ABC transporters_Homo sapiens_hsa02010 | 0.82737280 |
49 | Carbon metabolism_Homo sapiens_hsa01200 | 0.82639300 |
50 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.81965092 |
51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.80205464 |
52 | Salmonella infection_Homo sapiens_hsa05132 | 0.80194489 |
53 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.80098856 |
54 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.79931077 |
55 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.76989688 |
56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.72592061 |
57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70048055 |
58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.69060778 |
59 | Peroxisome_Homo sapiens_hsa04146 | 0.64765277 |
60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63517888 |
61 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.59479052 |
62 | Thyroid cancer_Homo sapiens_hsa05216 | 0.58807120 |
63 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.58621108 |
64 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.58442975 |
65 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.58226067 |
66 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.56231572 |
67 | Allograft rejection_Homo sapiens_hsa05330 | 0.56065704 |
68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56033600 |
69 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55574073 |
70 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.54805849 |
71 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54349393 |
72 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.52297931 |
73 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.51864825 |
74 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.50569800 |
75 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.50549713 |
76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49568261 |
77 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.48525936 |
78 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.47600973 |
79 | Hepatitis C_Homo sapiens_hsa05160 | 0.47294030 |
80 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.47262931 |
81 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.46873267 |
82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44441015 |
83 | Leishmaniasis_Homo sapiens_hsa05140 | 0.44431912 |
84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42994286 |
85 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.41381400 |
86 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39200504 |
87 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39015183 |
88 | Salivary secretion_Homo sapiens_hsa04970 | 0.37239241 |
89 | Bladder cancer_Homo sapiens_hsa05219 | 0.37095353 |
90 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.35574701 |
91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34473209 |
92 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.30751154 |
93 | Amoebiasis_Homo sapiens_hsa05146 | 0.30579744 |
94 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.30468325 |
95 | Platelet activation_Homo sapiens_hsa04611 | 0.29423743 |
96 | Pertussis_Homo sapiens_hsa05133 | 0.28907955 |
97 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.28455717 |
98 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.27886729 |
99 | Renin secretion_Homo sapiens_hsa04924 | 0.27381090 |
100 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.27228470 |
101 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.26924412 |
102 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.25682124 |
103 | Legionellosis_Homo sapiens_hsa05134 | 0.24926770 |
104 | Influenza A_Homo sapiens_hsa05164 | 0.24276542 |
105 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.23821792 |
106 | Metabolic pathways_Homo sapiens_hsa01100 | 0.22950325 |
107 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.22812932 |
108 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.22592283 |
109 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.22456888 |
110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.21727422 |
111 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.20994627 |
112 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.20013778 |
113 | Insulin resistance_Homo sapiens_hsa04931 | 0.19693841 |
114 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.19565159 |
115 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.18354657 |
116 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.18287669 |
117 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.17967266 |
118 | Retinol metabolism_Homo sapiens_hsa00830 | 0.17196143 |
119 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.17073808 |
120 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.15174935 |
121 | Other glycan degradation_Homo sapiens_hsa00511 | 0.14616755 |
122 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.12320460 |
123 | Cocaine addiction_Homo sapiens_hsa05030 | 0.11852977 |
124 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.11367719 |
125 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11314354 |
126 | Shigellosis_Homo sapiens_hsa05131 | 0.10602947 |
127 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.10541090 |
128 | Viral myocarditis_Homo sapiens_hsa05416 | 0.09199500 |
129 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.08372841 |
130 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.06695292 |
131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.06460324 |
132 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.05530373 |